Head-to-head · WeighScore
NowPatient vs UR Meds
The verdict
NowPatient takes it — 65.5/100 to 54.9/100.
NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NowPatient | UR Meds |
|---|---|---|
| WeighScore | 65.5/100 | 54.9/100 |
| Grade | C | C |
| Scorecard rank | #217 | #452 |
| Semaglutide | $1,349/mo (brand Wegovy) | Not disclosed |
| Tirzepatide | $1,069/mo (brand Mounjaro, promotional rate) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #217 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Graded #452 · C
Strengths
- GLP-1 weight-loss care from $179/mo with the same price at every dose
- No monthly membership; cancel anytime; no insurance required
- Multi-pillar: also peptides, men's/women's health, hair, and longevity
- Runs on the OpenLoop Health telehealth platform with US-licensed providers
- 10,000+ patients served
Where it loses points
- Specific GLP-1 molecule (semaglutide vs tirzepatide) not named on the marketing site
- Compounding pharmacy partner not named
- States of operation not published
- LegitScript 'Certified' shown via a self-hosted badge linking to the generic LegitScript site (not independently verifiable)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.